Inovio Pharmaceuticals Inc (INO)

[Ckbike]

Just ask Amarin shareholders why INO might want to partner. Amarin's Vascepa received FDA approval 7/26/12. Instead of partnering or being bought out they chose to go it alone. They raised cash, hired a sales force of 250 and are slowly seeing increasing RX numbers. However, the share price has dropped from a post approval high of $15.60 to the current $5.31. They have another PDUFDA date with the FDA for the much larger Anchor indication but their experience so far demonstrates the difficulty a small bio has with marketing and selling a drug on their own. And yes, I'm a frustrated AMRN shareholder.